{"name":"Raymond T. Chung, MD","slug":"raymond-t-chung-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"glecaprevir/pibrentasvir tablets","genericName":"glecaprevir/pibrentasvir tablets","slug":"glecaprevir-pibrentasvir-tablets","indication":"Chronic hepatitis C virus infection (all genotypes 1-6), treatment-naïve and treatment-experienced patients","status":"marketed"}]}],"pipeline":[{"name":"glecaprevir/pibrentasvir tablets","genericName":"glecaprevir/pibrentasvir tablets","slug":"glecaprevir-pibrentasvir-tablets","phase":"marketed","mechanism":"Glecaprevir and pibrentasvir are direct-acting antivirals that inhibit hepatitis C virus (HCV) NS3/4A protease and NS5A protein, respectively, blocking viral replication.","indications":["Chronic hepatitis C virus infection (all genotypes 1-6), treatment-naïve and treatment-experienced patients","Hepatitis C virus infection in patients with compensated cirrhosis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPcDVxR2h3bUlVdnpDV3pnV01WVzNIcHRZRzlseW1yRVhjY295ZEQ3VUhCM2NJTEMwMkh3ZDExUTljVmJ4ZTc3M21YT1ctWUNud3VpYUJMUlNWTFk0eG9QNDdqRXJNMFBlUFpBdVRWTkJPdng4RXRsc2ZhOXJfUHF3UG1PM1FKeEs1cnM0OWozQVM0aW9McmhlOVlDRkQ?oc=5","date":"2025-04-01","type":"pipeline","source":"Medscape","summary":"Could Statins Prevent Hepatocellular Carcinoma? - Medscape","headline":"Could Statins Prevent Hepatocellular Carcinoma?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPLVBwSDVKWFpPVlBHSUxvYlc2aFlpdkpwdzdlc3VsTmNhdUQ4M3J1NUtBcFZwSURCM2ZhUjRzam1maU9jd2VkUHRtQzFIQ0stWWREMWFtbllMSDd0ODB2SjJoQVExZFFZejc1RDQ2dTBpRWxmcjNzbFV5aVozTHEwSzhpRVFLUQ?oc=5","date":"2024-09-09","type":"pipeline","source":"Medical Xpress","summary":"Q&A: Researchers discuss statin, metformin, and aspirin use with hepatocellular carcinoma - Medical Xpress","headline":"Q&A: Researchers discuss statin, metformin, and aspirin use with hepatocellular carcinoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE4teFJRQ243WTFEd01tdi1QbjU1MC1VNE9LbmE5N3NBVmxxRkd3VXg5R012SDlsMENiNTVwcnpDY2E2RUlfMUh5VGp5RTJyMmFESGVSUXktYl9YeGRIb01LbQ?oc=5","date":"2020-03-11","type":"pipeline","source":"NEJM","summary":"Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality - NEJM","headline":"Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE1WX0IzNFAtVWNGMndybkhpZV9NVW52TlhyM3pVWllJem1ITGdvSTNJQ1BBaEpOekQ4bTlKcEJ6aTdhbmlsS3dYcXZ3aF9nRXRBTEZHWjRIR2NlMUxDel9TMDVTYw?oc=5","date":"2014-11-13","type":"deal","source":"RSNA Journals","summary":"Shear-Wave Elastography for the Estimation of Liver Fibrosis in Chronic Liver Disease: Determining Accuracy and Ideal Site for MeasurementRadiology - RSNA Journals","headline":"Shear-Wave Elastography for the Estimation of Liver Fibrosis in Chronic Liver Disease: Determining Accuracy and Ideal Si","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}